SO010PATIROMER PROTECTED AGAINST RECURRENT HYPERKALEMIA FOR UP TO 52 WEEKS IN PATIENTS WITH DIABETIC KIDNEY DISEASE (DKD) RECEIVING COMBINED RAAS INHIBITOR THERAPY

Journal article

Peer reviewed

Murray Epstein, Martha Mayo, Dahlia Garza, Rezi Zawadzki, Alain Romero, Lance Berman, Daniel Wilson and George Bakris

Nephrology, dialysis, transplantation, Vol.31(suppl_1), pp.i4-i4

2016-05-01

Metrics

1 Record Views

Title: SO010PATIROMER PROTECTED AGAINST RECURRENT HYPERKALEMIA FOR UP TO 52 WEEKS IN PATIENTS WITH DIABETIC KIDNEY DISEASE (DKD) RECEIVING COMBINED RAAS INHIBITOR THERAPY
Creators: Murray Epstein - University of Miami
Martha Mayo - 2Relypsa, Inc., Clinical Development, Redwood City, CA
Dahlia Garza - 3Relypsa, Inc., Medical Affairs, Redwood City, CA
Rezi Zawadzki - 4Relypsa, Inc., Biostatistics, Redwood City, CA
Alain Romero - 3Relypsa, Inc., Medical Affairs, Redwood City, CA
Lance Berman - 3Relypsa, Inc., Medical Affairs, Redwood City, CA
Daniel Wilson - 3Relypsa, Inc., Medical Affairs, Redwood City, CA
George Bakris - University of Chicago
Publication Details: Nephrology, dialysis, transplantation, Vol.31(suppl_1), pp.i4-i4
Academic Unit: Benefits - Other; Human Resources
Language: English
Resource Type: Journal article
Record Identifier: 991031740172902976